Residual Tumor Characteristics Following Neoadjuvant Chemotherapy in Breast Cancer
Journal: Austin Journal of Cancer and Clinical Research (Vol.2, No. 7)Publication Date: 2015-08-11
Authors : Mani CS; Chander V; Kurian A; Subramani A; Mallikarjun VS; Mahalingam S; Ramakrishnan V;
Page : 1-6
Keywords : Breast cancer; Nucleoli; mAgNOR; Exome analysis; Neoadjuvant chemotherapy; Residual tumor;
Abstract
Neoadjuvant chemotherapy for breast cancer leaves behind a residual tumor that is substantially different in its characteristics from the original tumor. The histological changes and receptor changes have been systematically evaluated in large studies. However, the nucleolar morphology of the residual cancer has not been well characterized. This study evaluated the nucleolar morphology in the residual cancer using haematoxylin eosin for evaluation of nucleolar number and size in relation to mitotic index, mAgNOR assessment, and an immunohistochemistry panel consisting of Ki-67, p53, CCND1, E-Cad, ER, PR, Her2Neu, CD3, CD8 and CD68. Another sample of patients were studied by exome analysis of a 344 candidate cancer gene panel. The results were collated to infer the nature of the residual tumor. There was an increase in nucleolar number and size following neoadjuvant chemotherapy. The mitotic rate, and positive staining for Ki-67 and CCND1 were reduced in the residual tumor. 344 candidate cancer gene panel exome analyses showed residual tumor with fewer mutations and the more common known driver mutation in breast cancer such as CREBP, ERBB2, PARP, TOP2A, P53 etc. COL1A1 was the only gene mutation demonstrated in the residual tumor that was not found in the untreated primary surgical group.
Other Latest Articles
- The Roles of Ultrasonography in the Management of Axillary Node Metastases in Breast Cancer
- Establishment and Characterization of Six Primary Pancreatic Cancer Cell Lines
- Reproducibility of Aberrant Lymphatic Drainage in a Melanoma Patient with Clinical History of Previous Axillary Lymph Node Dissection from a Breast Cancer: A Case Report
- Role of Vats in Management of Malignant Pleural Effusion with Suspected Diaphragmatic Fenestrations
- Anticancer Effects and uses of Melatonin: A Review
Last modified: 2016-07-04 20:40:53